HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

X Guo Selected Research

Rituximab (Mabthera)

3/2016Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study.
9/2012Successful treatment of acquired haemophilia in a patient with bullous pemphigoid with single-dosing regimen of rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


X Guo Research Topics

Disease

43Neoplasms (Cancer)
03/2024 - 04/2000
12Inflammation (Inflammations)
03/2024 - 05/2000
7Neoplasm Metastasis (Metastasis)
11/2023 - 04/2000
7Type 2 Diabetes Mellitus (MODY)
10/2023 - 12/2012
6Obesity
05/2020 - 04/2000
6Motor Skills Disorders (Motor Skills Disorder)
01/2018 - 11/2012
6Kashin-Beck Disease
01/2017 - 01/2009
5Hepatocellular Carcinoma (Hepatoma)
06/2022 - 01/2014
5Breast Neoplasms (Breast Cancer)
01/2018 - 04/2000
5Infections
12/2017 - 01/2007
5Nasopharyngeal Carcinoma
09/2014 - 01/2000
5Carcinoma (Carcinomatosis)
12/2001 - 02/2000
5Colitis
08/2001 - 01/2001
4Pneumonia (Pneumonitis)
09/2020 - 02/2011
4Hypertension (High Blood Pressure)
01/2016 - 06/2001
4Carcinogenesis
01/2011 - 04/2000
3Ovarian Neoplasms (Ovarian Cancer)
08/2023 - 01/2009
3Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 03/2001
3Osteoarthritis
01/2022 - 01/2012
3Communicable Diseases (Infectious Diseases)
12/2021 - 12/2017
3Obstructive Sleep Apnea
01/2021 - 11/2001
3Stomach Neoplasms (Stomach Cancer)
02/2020 - 07/2010
3Lymphatic Metastasis
02/2020 - 04/2000
3Adenocarcinoma
02/2020 - 12/2008
3Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 03/2011
3Insulin Resistance
04/2019 - 06/2013
3Atrial Fibrillation
01/2019 - 02/2001
3Wounds and Injuries (Trauma)
04/2018 - 06/2001
3Dyslipidemias (Dyslipidemia)
01/2016 - 04/2007
3Scoliosis
01/2006 - 08/2000
2Flatulence
01/2024 - 02/2020
2Lung Injury
11/2023 - 03/2021
2Pulmonary Edema
11/2023 - 03/2021
2Astigmatism
07/2023 - 11/2000
2Non-alcoholic Fatty Liver Disease
12/2022 - 08/2015
2Body Weight (Weight, Body)
12/2022 - 07/2015
2Thrombosis (Thrombus)
06/2022 - 12/2001
2Osteoporosis
03/2022 - 08/2019
2Hepatitis B
10/2020 - 05/2001
2Liver Neoplasms (Liver Cancer)
10/2020 - 02/2015
2Strabismus (Squint)
03/2020 - 08/2016
2Mental Disorders (Mental Disorder)
02/2020 - 01/2017
2Laryngeal Neoplasms (Laryngeal Cancer)
05/2019 - 04/2000
2Necrosis
08/2018 - 01/2012
2Prostatic Neoplasms (Prostate Cancer)
04/2018 - 03/2000
2Glioma (Gliomas)
01/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
11/2023 - 04/2000
20Messenger RNA (mRNA)IBA
03/2024 - 03/2000
9DNA (Deoxyribonucleic Acid)IBA
01/2016 - 04/2000
8MicroRNAs (MicroRNA)IBA
03/2022 - 03/2009
8Glucose (Dextrose)FDA LinkGeneric
04/2019 - 02/2000
7Biomarkers (Surrogate Marker)IBA
03/2022 - 07/2010
6Insulin (Novolin)FDA Link
04/2019 - 08/2012
6dicarboxydine (DCD)IBA
01/2018 - 11/2012
5Peroxidase (Myeloperoxidase)IBA
11/2023 - 05/2000
5VaccinesIBA
12/2021 - 10/2006
4Interleukin-6 (Interleukin 6)IBA
03/2024 - 01/2001
4CytokinesIBA
08/2018 - 09/2000
4Transcription Factors (Transcription Factor)IBA
08/2017 - 04/2000
4EnzymesIBA
06/2017 - 05/2000
3Triglycerides (Triacylglycerol)IBA
10/2023 - 01/2020
3HDL CholesterolIBA
10/2023 - 02/2007
3Insulin-Like Growth Factor I (IGF-1)IBA
03/2022 - 12/2001
3SmokeIBA
06/2021 - 01/2001
3LipidsIBA
01/2020 - 04/2000
3Mitochondrial DNA (mtDNA)IBA
01/2019 - 07/2000
3Indicators and Reagents (Reagents)IBA
01/2019 - 03/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2018 - 01/2000
3salicylhydroxamic acid (SHAM)IBA
07/2015 - 09/2000
3Lipoprotein Lipase (Diacylglycerol Lipase)IBA
04/2015 - 04/2000
3Therapeutic UsesIBA
06/2014 - 02/2001
3LigandsIBA
02/2011 - 05/2001
3Sulfonic AcidsIBA
11/2001 - 01/2001
3Surface-Active Agents (Surfactants)IBA
09/2001 - 05/2000
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 12/2001
2LDL CholesterolIBA
10/2023 - 12/2022
2Phenobarbital (Luminal)FDA Link
08/2023 - 01/2018
2Uric Acid (Urate)IBA
12/2022 - 01/2017
2oxidized low density lipoproteinIBA
12/2022 - 04/2000
2Immune Checkpoint InhibitorsIBA
11/2022 - 08/2022
2EpitopesIBA
09/2022 - 12/2012
2GemcitabineFDA Link
08/2022 - 12/2008
21-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2020 - 01/2020
2Long Noncoding RNAIBA
11/2020 - 09/2017
2Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
09/2020 - 09/2020
2CholesterolIBA
01/2020 - 11/2010
2Small Interfering RNA (siRNA)IBA
05/2019 - 12/2008
2Apolipoproteins E (ApoE)IBA
01/2019 - 09/2007
2micaIBA
04/2018 - 12/2017
2Fibrinogen (Factor I)FDA Link
01/2018 - 09/2014
2MineralsIBA
01/2018 - 08/2000

Therapy/Procedure

11Therapeutics
08/2022 - 12/2001
5Drug Therapy (Chemotherapy)
01/2023 - 12/2008
3Stents
12/2022 - 08/2016
2Length of Stay
01/2024 - 02/2020
2Radiotherapy
11/2023 - 02/2020
2Immunotherapy
01/2023 - 01/2020
2Photochemotherapy (Photodynamic Therapy)
12/2020 - 01/2020
2Esophagectomy
06/2020 - 12/2001
2Anesthesia
03/2020 - 01/2000